Hyperphosphatemia Therapeutics Market to Hit Sales of $3.53 Billion by 2028 | Over 93% Physicians Prefer Binders For Treating Hyperphosphatemia
November 02, 2022 08:55 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Hyperphosphatemia is a condition characterized by elevated levels of phosphate in the blood. Phosphate plays an important role in cell function...
RNA Therapeutics market is projected to grow at a CAGR of 18.68% by 2032: Visiongain Reports Ltd
October 28, 2022 05:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report: RNA Therapeutics Market, (COVID-19 Impact Analysis):- Market Segment by Type {RNA Antisense Technologies, RNA Interference (RNAi) Technologies}, Market Segment...
Sleep Apnea Devices Market to hit USD 14.5 billion by 2030, says Global Market Insights Inc.
October 27, 2022 09:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 27, 2022 (GLOBE NEWSWIRE) -- The sleep apnea devices market value is anticipated to exceed USD 14.5 billion by 2030, according to a new research report by Global...
Global Albumin Market Projected to Beat $10,239.0 Million, Growing with a CAGR of 6.1% in the 2022-2032 Timeframe [250-Pages] | Conclusion by Research Dive
October 11, 2022 09:07 ET
|
Research Dive
New York, USA, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global albumin market. As per the report, the market is anticipated to garner $10,239.0 million and...
Palisade Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 23, 2022 16:30 ET
|
Palisade Bio, Inc.
Carlsbad, CA, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI)...
Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants
September 21, 2022 12:54 ET
|
Lactiga, Inc
NORTH BRUNSWICK, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Lactiga Therapeutics, an early-stage biotechnology company focused on improving the quality of life of patients with primary...
Praxis Precision Medicines to Present at Guggenheim Nantucket Therapeutics Conference
September 21, 2022 09:00 ET
|
Praxis Precision Medicines, Inc.
BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
Merck Joins Accumulus Synergy as a Sponsor to Transform the Global Drug Regulatory Submission Process
September 20, 2022 08:30 ET
|
Accumulus Synergy
BURLINGAME, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Accumulus Synergy, a non-profit organization working to develop an information and data exchange platform aimed at transforming how life...
Epilepsy Therapeutics Market to Exceed Value of US$ 14.9 Bn by 2031, observes TMR Study
August 16, 2022 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Industry players concur that there is an unmet need for effective therapeutics for managing...
Compass Therapeutics to Present at the 13th Annual Wedbush PacGrow Healthcare Conference
August 02, 2022 08:00 ET
|
Compass Therapeutics
BOSTON, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer,...